These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 16702955)

  • 41. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
    Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
    Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
    Jernberg-Wiklund H; Nilsson K
    Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells.
    Izban KF; Ergin M; Martinez RL; Alkan S
    Mod Pathol; 2000 Dec; 13(12):1324-31. PubMed ID: 11144929
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization.
    Pullen SS; Labadia ME; Ingraham RH; McWhirter SM; Everdeen DS; Alber T; Crute JJ; Kehry MR
    Biochemistry; 1999 Aug; 38(31):10168-77. PubMed ID: 10433725
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TRAF6 activation of PI 3-kinase-dependent cytoskeletal changes is cooperative with Ras and is mediated by an interaction with cytoplasmic Src.
    Wang KZ; Wara-Aswapati N; Boch JA; Yoshida Y; Hu CD; Galson DL; Auron PE
    J Cell Sci; 2006 Apr; 119(Pt 8):1579-91. PubMed ID: 16569657
    [TBL] [Abstract][Full Text] [Related]  

  • 46. BS69, a specific adaptor in the latent membrane protein 1-mediated c-Jun N-terminal kinase pathway.
    Wan J; Zhang W; Wu L; Bai T; Zhang M; Lo KW; Chui YL; Cui Y; Tao Q; Yamamoto M; Akira S; Wu Z
    Mol Cell Biol; 2006 Jan; 26(2):448-56. PubMed ID: 16382137
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunosuppressive effect of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through the inhibition of T-lymphocyte proliferation and IL-2 production.
    Yun CH; Son CG; Jung U; Han SH
    Toxicology; 2006 Jan; 217(1):31-8. PubMed ID: 16168555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combined TRAF6 Targeting and Proteasome Blockade Has Anti-myeloma and Anti-Bone Resorptive Effects.
    Chen H; Li M; Sanchez E; Wang CS; Lee T; Soof CM; Casas CE; Cao J; Xie C; Udd KA; DeCorso K; Tang GY; Spektor TM; Berenson JR
    Mol Cancer Res; 2017 May; 15(5):598-609. PubMed ID: 28122920
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The atypical PKC-interacting protein p62 channels NF-kappaB activation by the IL-1-TRAF6 pathway.
    Sanz L; Diaz-Meco MT; Nakano H; Moscat J
    EMBO J; 2000 Apr; 19(7):1576-86. PubMed ID: 10747026
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TIFAB inhibits TIFA, TRAF-interacting protein with a forkhead-associated domain.
    Matsumura T; Semba K; Azuma S; Ikawa S; Gohda J; Akiyama T; Inoue J
    Biochem Biophys Res Commun; 2004 Apr; 317(1):230-4. PubMed ID: 15047173
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TNF receptor-associated factor-1 (TRAF1) negatively regulates Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-mediated signaling.
    Su X; Li S; Meng M; Qian W; Xie W; Chen D; Zhai Z; Shu HB
    Eur J Immunol; 2006 Jan; 36(1):199-206. PubMed ID: 16323247
    [TBL] [Abstract][Full Text] [Related]  

  • 52. RIP kinase is involved in arsenic-induced apoptosis in multiple myeloma cells.
    Bajenova O; Tang B; Pearse R; Feinman R; Childs BH; Michaeli J
    Apoptosis; 2004 Sep; 9(5):561-71. PubMed ID: 15314284
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The mitochondrial serine protease HtrA2/Omi cleaves RIP1 during apoptosis of Ba/F3 cells induced by growth factor withdrawal.
    Vande Walle L; Wirawan E; Lamkanfi M; Festjens N; Verspurten J; Saelens X; Vanden Berghe T; Vandenabeele P
    Cell Res; 2010 Apr; 20(4):421-33. PubMed ID: 20125124
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PC cell-derived growth factor confers resistance to dexamethasone and promotes tumorigenesis in human multiple myeloma.
    Wang W; Hayashi J; Serrero G
    Clin Cancer Res; 2006 Jan; 12(1):49-56. PubMed ID: 16397023
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Silencing MR-1 attenuates inflammatory damage in mice heart induced by AngII.
    Dai W; Chen H; Jiang J; Kong W; Wang Y
    Biochem Biophys Res Commun; 2010 Jan; 391(3):1573-8. PubMed ID: 20040360
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glutaredoxin-1 regulates TRAF6 activation and the IL-1 receptor/TLR4 signalling.
    Chantzoura E; Prinarakis E; Panagopoulos D; Mosialos G; Spyrou G
    Biochem Biophys Res Commun; 2010 Dec; 403(3-4):335-9. PubMed ID: 21078302
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effects of down-regulated TRAF6 gene expression on the proliferation and apoptosis in multiple myeloma cells].
    Huang HM; Wang XF; Liu XX; Xu RR; Shi W; Ding RS; Jiang SH
    Zhonghua Xue Ye Xue Za Zhi; 2013 Nov; 34(11):941-5. PubMed ID: 24294849
    [TBL] [Abstract][Full Text] [Related]  

  • 58. siRNA-induced TRAF6 knockdown promotes the apoptosis and inhibits the invasion of human lung cancer SPC-A1 cells.
    He Z; Huang C; Lin G; Ye Y
    Oncol Rep; 2016 Apr; 35(4):1933-40. PubMed ID: 26847475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of Egr-1 by siRNA in prostate carcinoma cell lines is associated with decreased expression of AP-1 and NF-κB.
    Parra E; Ferreira J; Saenz L
    Int J Mol Med; 2011 Nov; 28(5):847-53. PubMed ID: 21743958
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signature.
    Olivier S; Close P; Castermans E; de Leval L; Tabruyn S; Chariot A; Malaise M; Merville MP; Bours V; Franchimont N
    Mol Pharmacol; 2006 May; 69(5):1615-23. PubMed ID: 16497877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.